Literature DB >> 21889550

Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity.

Amany A Abdin1, Naglaa I Sarhan.   

Abstract

The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of dopaminergic neurons in Parkinson's disease. Model of rotenone-induced parkinsonism in rats produced decrease in striatal complex I activity and reduced glutathione with increase in nitrites concentration and caspase-3 activity. This was confirmed by significant correlation of catalepsy score with neurochemical parameters. Moreover, electron microscopic examination of striatal neurons displayed ultrastructure affection as hyperchromatic nuclei and disrupted mitochondria that are typical features of undergoing apoptosis. Administration of L-dopa as replacement therapy, although caused symptomatic improvement in catalepsy score, but further worsening in neurochemical parameters. Therefore, efforts are not only to improve effect of L-dopa, but also to introduce drugs provide antiparkinsonian and neuroprotective effects. In this study, α-lipoic acid exhibited noticeable neuroprotective effects by a mechanism via intervention of mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways. Combination of α-lipoic acid efficiently halting deleterious toxic effects of L-dopa, revealed normalization of catalepsy score in addition to amelioration of neurochemical parameters and apparent preservation of striatal ultrastructure integrity, indicating benefit of both symptomatic and neuroprotective therapy. In conclusion, α-lipoic acid could be recommended as a disease-modifying therapy when given with L-dopa early in course of Parkinson's disease. Copyright Â
© 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889550     DOI: 10.1016/j.neures.2011.08.008

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  11 in total

1.  Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment.

Authors:  Tarsila Barros Moraes; Giovana Reche Dalazen; Carlos Eduardo Jacques; Raylane Silva de Freitas; Andrea Pereira Rosa; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2014-02-02       Impact factor: 3.584

Review 2.  Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?

Authors:  Satya Prakash Gupta; Sharawan Yadav; Naveen Kumar Singhal; Manindra Nath Tiwari; Sarad Kumar Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2013-07-31       Impact factor: 5.590

3.  Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.

Authors:  Ghada A Badawi; Mai A Abd El Fattah; Hala F Zaki; Moushira I El Sayed
Journal:  Inflammopharmacology       Date:  2017-03-04       Impact factor: 4.473

4.  Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.

Authors:  Haidy E Michel; Mariane G Tadros; Ahmed Esmat; Amani E Khalifa; Ahmed M Abdel-Tawab
Journal:  Mol Neurobiol       Date:  2016-08-11       Impact factor: 5.590

Review 5.  Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases.

Authors:  Carlos Fernández-Moriano; Elena González-Burgos; M Pilar Gómez-Serranillos
Journal:  Oxid Med Cell Longev       Date:  2015-04-29       Impact factor: 6.543

6.  Behavioral and neurochemical effects of alpha-lipoic Acid in the model of Parkinson's disease induced by unilateral stereotaxic injection of 6-ohda in rat.

Authors:  Dayane Pessoa de Araújo; Caren Nádia Soares De Sousa; Paulo Victor Pontes Araújo; Carlos Eduardo de Souza Menezes; Francisca Taciana Sousa Rodrigues; Sarah Souza Escudeiro; Nicole Brito Cortez Lima; Manoel Claúdio Azevedo Patrocínio; Lissiana Magna Vasconcelos Aguiar; Glauce Socorro de Barros Viana; Silvânia Maria Mendes Vasconcelos
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

7.  Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders.

Authors:  Slawomir Michalak; Jolanta Florczak-Wyspiańska; Joanna Rybacka-Mossakowska; Wojciech Ambrosius; Krystyna Osztynowicz; Aleksandra Baszczuk; Wojciech Kozubski; Ewa Wysocka
Journal:  Oxid Med Cell Longev       Date:  2017-09-10       Impact factor: 6.543

Review 8.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

Review 9.  Mitochondria: A Therapeutic Target for Parkinson's Disease?

Authors:  Yu Luo; Alan Hoffer; Barry Hoffer; Xin Qi
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

Review 10.  The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders.

Authors:  Manish Kumar Tripathi; Maryam Kartawy; Haitham Amal
Journal:  Redox Biol       Date:  2020-05-15       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.